What is the average price target for MEDISTIM ASA (MEDI.OL) stock?
7 analysts have analysed MEDI.OL and the average price target is 260.1 NOK. This implies a price increase of 23.86% is expected in the next year compared to the current price of 210.
MEDISTIM ASA (MEDI.OL) Forecast, Price Target & Analyst Ratings
OSL:MEDI • NO0010159684
Current stock price
210 NOK
+2 (+0.96%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MEDISTIM ASA (MEDI.OL).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
NOK260.10
Upside
+ 23.86%
From current price of NOK210.00 to mean target of NOK260.10, Based on 7 analyst forecasts
Low
NOK202.00
Median
NOK260.10
High
NOK325.50
Price Target Revisions
1 Month
-1.92%
3 Months
-1.92%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for MEDI.OL. The average price target is 260.1 NOK. This implies a price increase of 23.86% is expected in the next year compared to the current price of 210.
The average price target has been revised downward by 1.92% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.71%
MEDI.OL was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about MEDI.OL.
In the previous month the buy percentage consensus was at a similar level.
MEDI.OL was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 7, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2026 - 2028
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 526.364M 7.00% | 562.599M 6.88% | 699.767M 24.38% | 706.86M 1.01% | 762.96M 7.94% | 871.94M 14.28% | |
| EBITDA YoY % growth | 155.099M -5.74% | 155.586M 0.31% | 212.211M 36.39% | 205.02M -3.39% | 221.34M 7.96% | 300.84M 35.92% | |
| EBIT YoY % growth | 131.442M -6.94% | 131.076M -0.28% | 196.196M 49.68% | 198.9M 1.38% | 220.32M 10.77% | 245.82M 11.57% | |
| Operating Margin | 24.97% | 23.30% | 28.04% | 28.14% | 28.88% | 28.19% | |
| EPS YoY % growth | 5.67 -4.81% | N/A 7.04% | N/A 16.97% | 7.81 10.06% | 8.48 8.49% | 11.42 34.75% |
All data in NOK
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in NOK
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
17.18%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
9.96%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
20.16%
EBIT Next 5 Year
N/A
MEDISTIM ASA / MEDI.OL Forecast FAQ
What is the next earnings date for MEDI stock?
MEDISTIM ASA (MEDI.OL) will report earnings on 2026-05-07.
Can you provide the analyst count for MEDISTIM ASA stock?
The number of analysts covering MEDISTIM ASA (MEDI.OL) is 7.